Deutsche Bank analyst George Hill initiates coverage on Clover Health (NASDAQ: CLOV) with a Buy rating and a price target of $6.00.

For an analyst ratings summary and ratings history on Clover Health click here. For more ratings news on Clover Health click here.

Shares of Clover Health closed at $4.34 yesterday.